Abstract
As the world continues to battle the Covid-19 pandemic, innovation and technology have found a new battleground. Against the backdrop of the emerging patent controversies surrounding Covid-19 vaccines and therapeutics, this opinion reconsiders the theoretical justification for the grant of pharmaceutical patents.
| Original language | English |
|---|---|
| Pages (from-to) | 695-697 |
| Journal | European Intellectual Property Review |
| Volume | 42 |
| Issue number | 11 |
| Publication status | Published - 20 Nov 2020 |
Bibliographical note
Month information for this publication is provided by the author(s) concerned.Research Keywords
- Coronavirus
- Morals and law
- Patentable inventions
- Patents
- Pharmaceuticals
